We are an experienced team with internal drug discovery and development expertise focused on building a pipeline of best-in-class oral drugs for liver and gastrointestinal diseases.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $123M
Founded date: 2014
Investors 8
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.06.2018 | Series C | $65M | New Enterp... |
| 07.12.2017 | Series B | $22M | - |
| 05.08.2015 | Series A | $36M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 14.10.2020 | RayzeBio debuts with $45M to target tumors with radiopharmac... | Radiation, one of the most widely used and effective cancer therapies, is traditionally administered... | fiercebiot... |
| 16.09.2020 | Metacrine, a Rich Heyman biotech targeting NASH and othe... | A Rich Heyman-backed startup focusing on NASH treatments, as well as other liver, GI and meta... | endpts.com... |
| 11.06.2018 | Term Sheet — Monday, June 11 | ROUND TWO Good morning, Term Sheet readers. Paid Content How can you protect what you can't see? Fro... | fortune.co... |
| 10.06.2018 | NEA Joins $65M Series C for Metacrine | SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company de... | citybizlis... |
| 10.06.2018 | Venrock Leads $65M Series C for Metacrine | SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., an innovative biotechnology company de... | citybizlis... |
| 08.06.2018 | Metacrine Completes $65M Series C Financing | Metacrine, Inc., a San Diego, CA-based innovative biotechnology company developing therapies to bene... | finsmes.co... |
| 08.06.2018 | Metacrine Completes $65M Series C Financing | SAN DIEGO, CA, Biotechnology company has completed a Series C financing which raised $65 million. ... | vcnewsdail... |
| 06.06.2018 | Metacrine raises $65M to kick off NASH clinical testing | Metacrine raised $65 million in a series C round to fund the clinical development of its early stage... | fiercebiot... |
| 06.06.2018 | Metacrine Completes $65 Million Series C Financing | - | lifesciven... |
| 06.06.2018 | Metacrine raises $65M to kick off NASH clinical testing | Metacrine raised $65 million in a series C round to fund the clinical development of its early stage... | fiercebiot... |
Show more